Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models.
about
Anatomical and molecular imaging of skin cancerPhage display in molecular imaging and diagnosis of cancer.Malignant melanoma and melanocortin 1 receptor.Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma.64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analogReplacement of the Lys linker with an Arg linker resulting in improved melanoma uptake and reduced renal uptake of Tc-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptideReduction of the ring size of radiolabeled lactam bridge-cyclized alpha-MSH peptide, resulting in enhanced melanoma uptakeTargeted melanoma imaging and therapy with radiolabeled alpha-melanocyte stimulating hormone peptide analoguesGallium-67-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide for primary and metastatic melanoma imaging.Effects of the amino acid linkers on the melanoma-targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-MSH peptides.A preclinical 188Re tumor therapeutic investigation using MORF/cMORF pretargeting and an antiTAG-72 antibody CC49.Tc-99m-labeled RGD-conjugated alpha-melanocyte stimulating hormone hybrid peptides with reduced renal uptakePeptide-targeted radionuclide therapy for melanoma.Structural modification on the Lys linker enhanced tumor to kidney uptake ratios of 99mTc-labeled RGD-conjugated α-MSH hybrid peptides.Gallium-67-labeled lactam bridge-cyclized alpha-MSH peptides with enhanced melanoma uptake and reduced renal uptake.Cu-64-labeled lactam bridge-cyclized α-MSH peptides for PET imaging of melanoma203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection.Design and evaluation of new Tc-99m-labeled lactam bridge-cyclized alpha-MSH peptides for melanoma imaging111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide analogues for melanoma imaging.Evaluation of a novel Arg-Gly-Asp-conjugated α-melanocyte stimulating hormone hybrid peptide for potential melanoma therapy.Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptideMelanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide.Charged-particle emission tomography.Melanoma targeting property of a Lu-177-labeled lactam bridge-cyclized alpha-MSH peptideRadiolabeled peptides: valuable tools for the detection and treatment of cancerNull functions in three-dimensional imaging of alpha and beta particles.Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor.
P2860
Q30476227-64E1D53E-D274-4419-A24A-789AC038B830Q33532734-7ED6113A-17F4-4216-8E4A-0E59205B8995Q33782773-16E50CD2-D068-4DC3-92A3-0117878CB27DQ33853594-3123BBED-ED33-42EA-92F0-867483E5B215Q34083332-3FE3B585-3131-4A81-BD8A-1BF8E857654DQ34134418-39BBDF30-336C-4ADB-B1CD-C9E6EFC59E76Q34165263-85B12EE4-D0A2-46F1-8A18-16807079B2DEQ34386219-8A7FF064-DBAF-4AFC-872B-E75E870A4528Q34395062-270FA287-63B2-48F4-89AF-586B61B82332Q34436663-5BFA7BF5-D9D6-4A85-8B97-95E2B008054AQ34728904-20A0C159-4EBF-4E67-812C-A7946BA1C607Q34979175-BDF07722-1455-457F-AADD-A3174477165BQ35187053-60666F85-87A1-47E3-8C79-E0BE1027B5F6Q35393994-EA43CD11-8F6C-49A0-B5D0-26CB9BEE222FQ35947223-14CDDC21-3902-4060-8ABD-4DE41E612DECQ36230221-EA9A3A50-B43D-4444-A7AA-4D5BA186B0B4Q36346633-2CC4DB33-4593-4445-80AA-2D65D58446EEQ36723832-433B0D3A-59C1-47C8-AA2B-DA2A76A980A5Q36737564-2A0DFA01-28C2-4889-A86B-ED1F49324ACAQ36743097-1F99E8C8-499A-4AD4-9C00-93B1CA0F6923Q36753402-170F4404-9C2E-4425-9053-3B40CAE3B278Q37199680-C3CA3960-4623-4256-96EB-ADD692B85AF2Q37364790-F995A213-E6B8-4C8B-8298-41E41BA785DFQ37450632-B021C654-0C15-47F7-B590-C121D713F97EQ38859650-85467055-A24C-4C0B-86BE-B39729AF8862Q39183267-2ADE2E2D-51BE-4DDF-8FEB-BBFD0390C161Q39596344-2826A039-3782-4E0E-8508-DCEC8C80E757Q46141237-B05F4CE0-2779-4493-8626-DD5F05F871AFQ47135383-73DF5E6C-98AA-464B-972F-79529D99D9E1
P2860
Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Therapeutic efficacy of a 188R ...... melanoma-bearing mouse models.
@en
type
label
Therapeutic efficacy of a 188R ...... melanoma-bearing mouse models.
@en
prefLabel
Therapeutic efficacy of a 188R ...... melanoma-bearing mouse models.
@en
P2093
P1476
Therapeutic efficacy of a 188R ...... melanoma-bearing mouse models
@en
P2093
Darrell R Fisher
Nellie K Owen
Thomas P Quinn
Timothy J Hoffman
Yubin Miao
P304
P407
P577
2005-01-01T00:00:00Z